
Novo Nordisk sales by therapy area 2022-2024
Danish drug manufacturer Novo Nordisk generated some 207 billion kroner - or around 71 percent of its total sales - in the diabetes care segment. The rare disease segment was significantly lower, generating some 18.6 billion kroner of the company's total sales.